Id IUPAC Composition Core Glycan Type GlyTouCan UniCarb-DB Cartoon Biological associations
11 Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc Hex:3 HexNAc:2 Pauci-Mannose N-Linked G22768VO structure 11

    Mass spectrometry observed peptide

32 - Hex:5 HexNAc:4 dHex:2 Complex N-Linked G42962KI structure 32

    Disease

54 Fuc(a1-6)[GlcNAc(b1-4)]GlcNAc HexNAc:2 dHex:1 No-core N-Linked G21290RB structure 54

    Mass spectrometry observed peptide

70 Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-3)[Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc Hex:6 HexNAc:3 Hybrid N-Linked G16828VN structure 70

    Mass spectrometry observed peptide

75 Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc Hex:4 HexNAc:3 Complex N-Linked G28663KH structure 75

    Mass spectrometry observed peptide

99 NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc Hex:5 HexNAc:4 dHex:1 NeuAc:2 Complex N-Linked G72956NR structure 99

    Protein

  • Immunoglobulin gamma / Homo sapiens    P01857    P01860    P01859    P01861

    Disease

    Mass spectrometry observed peptide

131 Gal(b1-3)GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc Hex:4 HexNAc:4 Core 2 O-Linked G64206XB structure 131

    Disease

    Mass spectrometry observed peptide

138 - Hex:7 HexNAc:6 dHex:1 NeuAc:1 Complex N-Linked G68209WQ structure 138

    Mass spectrometry observed peptide

163 Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc Hex:3 HexNAc:3 dHex:1 NeuAc:1 Core 2 O-Linked G04114CX structure 163

    Disease

    Mass spectrometry observed peptide

175 Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-3)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc Hex:5 HexNAc:4 dHex:2 Complex N-Linked G25407RZ structure 175

    Mass spectrometry observed peptide

179 Gal(b1-4)GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc Hex:4 HexNAc:4 Core 2 O-Linked G00979XR structure 179

    Disease

    Mass spectrometry observed peptide

200 Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc Hex:3 HexNAc:3 dHex:1 Core 2 O-Linked G25538MM structure 200

    Disease

    Mass spectrometry observed peptide

211 Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-6)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc Hex:5 HexNAc:4 dHex:3 Complex N-Linked G52880ZN structure 211

    Mass spectrometry observed peptide

231 - Hex:4 HexNAc:4 NeuAc:1 Complex N-Linked G83204BU structure 231

    Disease

    Mass spectrometry observed peptide

248 Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc(a2-3) + NeuAc(a2-6)" Hex:5 HexNAc:4 dHex:1 NeuAc:2 Complex N-Linked G05610JO structure 248

    Mass spectrometry observed peptide

254 Man(a1-3)[Man(a1-6)]Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc Hex:5 HexNAc:3 dHex:1 Hybrid N-Linked G82942ZJ structure 254

    Mass spectrometry observed peptide

263 Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 4 x Man" Hex:7 HexNAc:2 High-Mannose N-Linked G43947VZ structure 263

    Mass spectrometry observed peptide

269 NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc Hex:5 HexNAc:4 dHex:1 NeuAc:1 Complex N-Linked G07392QY structure 269

    Mass spectrometry observed peptide

272 Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[Gal(b1-3)]GalNAc Hex:3 HexNAc:3 dHex:1 Core 2 O-Linked G70783BY structure 272

    Disease

    Mass spectrometry observed peptide

276 Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc Hex:4 HexNAc:4 dHex:3 NeuAc:1 Core 2 O-Linked G59658KK structure 276

    Disease

    Mass spectrometry observed peptide

279 Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x Man" Hex:5 HexNAc:2 High-Mannose N-Linked G45841FE structure 279
289 - Hex:5 HexNAc:5 NeuAc:1 Complex N-Linked G40734VV structure 289
311 Neu?c(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu?c(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc Hex:5 HexNAc:4 dHex:1 NeuAc:2 Complex N-Linked G56749GV structure 311

    Mass spectrometry observed peptide

314 - Hex:7 HexNAc:2 High-Mannose N-Linked G82020ZR structure 314
317 NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-3)[Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc Hex:6 HexNAc:3 NeuAc:1 Hybrid N-Linked G04576KS structure 317

    Mass spectrometry observed peptide

320 NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc Hex:5 HexNAc:5 NeuAc:1 Complex N-Linked G25140TA structure 320

    Mass spectrometry observed peptide

334 NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc Hex:4 HexNAc:4 dHex:1 NeuAc:1 Complex N-Linked G23295TF structure 334

    Mass spectrometry observed peptide

342 Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc Hex:3 HexNAc:3 dHex:1 NeuAc:1 Core 2 O-Linked G39523KI structure 342

    Disease

    Mass spectrometry observed peptide

350 - Hex:5 HexNAc:5 dHex:1 NeuAc:2 Complex N-Linked G65219TP structure 350
358 Gal(b1-4)GlcNAc(b1-3)Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc Hex:3 HexNAc:3 Core 2 O-Linked G34100DU structure 358

    Disease

    Mass spectrometry observed peptide

362 Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc Hex:8 HexNAc:2 High-Mannose N-Linked G40702WU structure 362

    Mass spectrometry observed peptide

419 Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc Hex:4 HexNAc:4 Complex N-Linked G89993FE structure 419

    Mass spectrometry observed peptide

427 Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc Hex:5 HexNAc:5 Complex N-Linked G52934AK structure 427

    Mass spectrometry observed peptide

432 - Hex:5 HexNAc:5 NeuAc:2 Complex N-Linked G33780DA structure 432

    Mass spectrometry observed peptide

469 NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc Hex:4 HexNAc:3 dHex:1 NeuAc:1 Complex N-Linked G84852GW structure 469

    Mass spectrometry observed peptide

474 Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x Man" Hex:6 HexNAc:2 High-Mannose N-Linked G21001NA structure 474

    Disease

    Mass spectrometry observed peptide

483 GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Gal(b1-4)" Hex:4 HexNAc:5 dHex:1 Complex N-Linked G75594YZ structure 483

    Mass spectrometry observed peptide

524 Fuc(a1-2)Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc Hex:2 HexNAc:2 dHex:1 Core 2 O-Linked G94514IB structure 524

    Disease

    Mass spectrometry observed peptide

566 Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-3)[Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc Hex:6 HexNAc:3 dHex:1 Hybrid N-Linked G11637WL structure 566

    Mass spectrometry observed peptide

629 GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc Hex:3 HexNAc:3 Complex N-Linked G61751GZ structure 629

    Mass spectrometry observed peptide

644 - Hex:6 HexNAc:5 Complex N-Linked G36131WL structure 644

    Mass spectrometry observed peptide

654 Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc Hex:7 HexNAc:2 High-Mannose N-Linked G83161QT structure 654

    Mass spectrometry observed peptide

657 Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Man" Hex:4 HexNAc:2 High-Mannose N-Linked G47909JD structure 657
678 GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc Hex:3 HexNAc:3 dHex:1 Complex N-Linked G07483YN structure 678

    Mass spectrometry observed peptide

682 Gal(b1-4)GlcNAc(b1-?)Man(a1-3)[Gal(b1-4)GlcNAc(b1-?)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc Hex:5 HexNAc:5 dHex:1 Complex N-Linked G03889MY structure 682

    Disease

    Mass spectrometry observed peptide

692 Gal(b1-3)GlcNAc(b1-3)Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]GalNAc Hex:3 HexNAc:3 Core 2 O-Linked G04765GH structure 692

    Disease

    Mass spectrometry observed peptide

693 NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc Hex:4 HexNAc:4 NeuAc:1 Complex N-Linked G90725ZC structure 693

    Mass spectrometry observed peptide

696 Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-3)]GalNAc Hex:3 HexNAc:3 dHex:1 Core 2 O-Linked G60067UC structure 696

    Disease

    Mass spectrometry observed peptide

750 Gal(b1-3)GalNAc(a + "Neu5Ac(a" Hex:1 HexNAc:1 NeuAc:1 Core 1 O-Linked G49582PC structure 750

    Disease

769 GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc Hex:4 HexNAc:5 dHex:1 NeuAc:1 Complex N-Linked G67942CH structure 769

    Mass spectrometry observed peptide